baber/WOPTO huggingface dataset:
Patent FI-893330-A0 (FI)
Inventor: POUTANEN TUOMO T
IPC: F16B15/00
Filed: 1989-07-07
Abstract: PCT No. PCT/FI89/00168 Sec. 371 Date Mar. 17, 1991 Sec. 102(e) Date Mar. 17, 1991 PCT Filed Sep. 8, 1989 PCT Pub. No. WO90/02854 PCT Pub. Date Mar. 22, 1990.A connector plate is provided which includes a plurality of connecting prongs which are, in use, pressed into wooden members to form a joint and which include at least one row of edge prongs that is folded down from the edge of the plate and that extends parallel to the longitudinal axis of the connector plate. A joint formed by a chord member and at least two abutting diagonals is connected together by connector plate which has a prong density that is asymmetrical with respect to longitudinal axis of the plate and has increased prong density at one side thereof. A joint structure provides a stiff, nonplastic joint.
Patent FI-914533-A0 (FI)
Inventor: DUGGAN MARK E
IPC: C07K5/06
Filed: 1991-09-26
Abstract: Fibrinogen receptor antagonists of the formula: <CHEM> are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
Patent FI-916145-A0 (FI)
Inventor: PERSELLO JACQUES
IPC: D21H19/40
Filed: 1991-12-27
Abstract: New silicoaluminate-based pigments characterised in that they have a surface chemistry such that their number of cationic sites, expressed in micromoles/m<2> of surface, is greater than 0.05. They are prepared by a process consisting in treating a silicoaluminate suspension exhibiting a pH of not more than 8 with an organic or inorganic salt of an at least divalent metal, then in raising the pH of the mixture again to a value higher than or equal to 3.5, in separating the treated silicoaluminate from the said mixture, and then in drying the recovered silicoaluminate. The invention also relates to the use of the said pigments as fillers for paper.
Patent FI-921533-A0 (FI)
Inventor: SKARPETOWSKI GRZEGORZ POLE
IPC: H02M1/084
Filed: 1992-04-07
Abstract: A universal algorithm is specified for producing control signals (11) for multi-stage and multi-phase converters (13, 14) which are line-commutated and self-commutated, by means of which algorithm it is possible to control different types of converters. The control algorithm may be implemented as hardware or software. The invention is particularly suitable for multi-system locomotives. A conversion can be made to a different locomotive supply system simply by changing the programming of a modulator (9) of a control signal generator (10). The modulator (9) and a pulse generator (8) receive modulator control signals (7) and pulse-generator control signals (6) respectively from a setting device (5) together with which they form the control signal generator (10). <IMAGE>
Patent FI-923604-A0 (FI)
Inventor: CHEN LAN BO
IPC: A61K31/42
Filed: 1992-08-12
Abstract: A pharmaceutical composition for treatment of cancer comprises:   (A) a therapeutically effective amount of at least one compound selected from the group consisting of compounds represented by the General Formula (I) <CHEM>  wherein X1 and X2, which may be the same or different, each represents O, S, Se, -CH=CH-, <CHEM>  or <CHEM>  Y1 represents O, S, Se, or <CHEM> R1 and R3, which may be the same or different, each represents an alkyl group; R2 represents an alkyl group, an aryl group or a heterocyclic group;  Z1 and Z2, which may be the same or different, each represents an atomic group necessary to form a 5- or 6-mebered ring; L1 represents a methine group or L1 and R3 may combine and form a 5- or 6-membered ring; R4 and R5, which may be the same or different, each represents a alkyl group; R6 and R7, which may be the same or different, each represents an alkyl group or an aryl group;     Q represents a pharmaceutically acceptable anion;     l represents 1 or 2; m and n, which may be the same or different, each represents 0 or 1; and   (B) a pharmaceutically acceptable carrier or diluent.
Patent FI-931917-A0 (FI)
Inventor: HAKALA OLLI
IPC: H04M1/724
Filed: 1993-04-28
Abstract: The object of the invention is an arrangement by which the abbreviated dialling memory of a mobile phone (1) can be expanded. In the arrangement according to the invention, an external device (2) is connected to the control bus (3) of the mobile phone (1). The abbreviated dialling memory of the mobile phone (1) is copied into the memory of the external device (2). The abbreviated dialling memory used by the mobile phone (1) is expanded and divided into logic parts. <IMAGE>
Patent FI-945904-A0 (FI)
Inventor: DEBREGEAS PATRICE
IPC: A61K47/02
Filed: 1994-12-15
Abstract: The present invention relates to a stable formulation of omeprazole microgranules containing a neutral core consisting of sugar and starch, characterized in that it contains an active layer consisting of a dilution of omeprazole in mannitol in substantially equal amounts. It also relates to a process for producing such formulations.
Patent FI-964815-A0 (FI)
Inventor: BRIGHTWELL CHRISTOPHER IAN
IPC: A61P25/24
Filed: 1996-12-02
Abstract: Compounds are disclosed which have the general formula A:    <IMAGE>  (A)  where Ra and Rb are each hydrogen or methyl and Rc is hydrogen, halo or C1-4 alkyl optionally in the form of a pharmaceutically acceptable acid addition salt. The compounds are useful in the treatment of CNS disorders.
Patent FI-970451-A0 (FI)
Inventor: WUBBEN MARIA ANNA
IPC: C12C11/11
Filed: 1997-02-03
Abstract: The invention provides pectins as new foam stabilizers for (temporary) foam heads in beverages, in particular in beers, especially beers of the pilsner type. These foam stabilizers are preferably obtained from hops, which is a constituent that is inherent in beer and accordingly offers the advantage, among others, that the foam stabilizers need to have no negative effect on the taste of the beer. Preferably, the pectins are obtained from hop cones or bines. It may be advantageous to partially saponify (de-esterify) the pectins, in connection with the number of charged groups on the pectins. In addition, the invention provides methods for obtaining the pectins and beverages stabilized with the pectins according to the invention.
Patent FI-972393-A0 (FI)
Inventor: THORVALDSSON TOMAS
IPC: B21C23/22
Filed: 1997-06-05
Abstract: A NiTi-based tube of memory metal is produced by extrusion, whereby: a) one starts off from a blank of a memory metal; b) a central hole is drilled in said blank; c) a core is introduced into the central hole, whereafter the blank is encased by a casing, and preferably also by two gables, whereby the blank is excluded from the surrounding atmosphere; d) the encased blank is heated and extruded; e) the ends of the extruded blank are removed; and f) also the core and the surrounding casing is removed. In this way, it has been accomplished to produce NiTi-based tubes of memory metal of hitherto unattained length, such as  >/=  1/2 m.
Patent FI-981404-A0 (FI)
Inventor: STEPHAN DOUGLAS W
IPC: C08F4/6592
Filed: 1998-06-17
Abstract: A catalyst component which is especially useful in so-called "slurry" or "gas phase" olefin polymerizations and which comprises an organmetallic complex of a froup 4 metal (having a cyclopentadienyl ligand and a phosohinimine ligand) and a particulate support. The catalyst component forms an excellent catalyst system when combined with an activator such as an aluminoxane or a so-called "substantially non-coordinating anion". In a preferred embodiment the organometallic complex and the activator are both deposited on the particulate support.
Patent FI-990274-A0 (FI)
Inventor: KAASALAINEN KAUKO
IPC: H01Q1/12
Filed: 1999-02-11
Abstract: A telescopic mast system, comprising a movable base (1); a telescopic mast (2) comprising an outer mast section (3) and an inner mast section (5) ; a power means (6) for turning the mast; stay ropes (10, 11, 12) for staying the mast so as to render it substantially immovable in the operating position; a stay beam (13, 14) which in the operating position (II) of the mast (2) can be extended laterally from the mast; a diverting element (15, 16) placed at the end of the stay beam; a coiling device (17, 18) for receiving the stay rope passed over the diverting element (15, 16) so as to coil up and tighten the stay rope. The stretcher device (19) comprises a slide (20) movable on and guided by the outer mast section (3); a bearing rod (21) pivotally connected by one end (22) to the slide (20) and by the other end to the base (1) so that the bearing rod (21) turns in a parallel plane with the mast and the power means (6); and a turning rod (25) pivotally connected by one end (26) to the slide (20) and by the other end (27) to the stay beam (13, 14) to turn the stay beam between the position (A) where it lies parallel to the mast and t-he outstretched position (B) as the slide is moved along the outer mast section by the action of the bearing rod when the mast is being turned by the power means between the transport position and the operating position. <IMAGE>
Patent AP-9400647-A0 (AP)
Title: Medicaments for use in treatment of HIV or cancer patients.
Inventor: DR AYUKO WASHINGTON ODUR
IPC: A61K31/192
Filed: 1994-05-20
Abstract: The invention discloses a compound for use in the treatment of cancer or disease caused by viral infection, which compound comprises an aromatic ring structure having at least one labile leaving group substituent and at least one electrophilic group substituent.
Patent IL-59899-A0 (IL)
Title: N-allenyl-acetanilides,their preparation and their use as fungicides
IPC: C07C233/88
Filed: 1980-04-23
Abstract: N-allenyl-acetanilides of the formula   <IMAGE>   in which R1 represents hydrogen, alkyl or halogen, R2 represents hydrogen or alkyl, R3 represents hydrogen or alkyl, R4 represents hydrogen or alkyl, R5 represents hydrogen or alkyl and R6 represents furyl, tetrahydrofuryl, thiophenyl or tetrahydrothiophenyl; isoxazolyl which is optionally substituted by alkyl; alkyl, alkenyl or alkynyl, in each case optionally substituted by cyano or thiocyano; dihalogenoalkyl; or the grouping CH2SR7, CH2Az, CH2OR7, CH2SR7, OR7 <IMAGE>  wherein R7 represents an optionally substituted alkyl, alkenyl, alkynyl or alkoxyalkyl radical and Az represents pyrazol-1-yl, 1,2,4-triazol-1-yl or imidazol-1-yl. which possess fungicidal properties.
Patent IL-72389-A0 (IL)
Title: Aqueous protein solutions which are stable towards denaturing,processes for their preparation and their use
IPC: A61K38/00
Filed: 1984-07-12
Abstract: The invention relates to aqueous solutions of proteins with a molecular weight above 8,500 daltons, which contain a compound of the formula I R2O-Xn-R3 (I) in which Xn is a chain of n members of the formula II or III   <IMAGE>   in any desired sequence, n denotes 2 to 200 and R1 denotes hydrogen, methyl or ethyl, it being possible for the radicals R1 to be identical or different but R1 being hydrogen in at least half of the chain members, and R2 and R3 are identical or different and denote hydrogen or an organic radical, to processes for their preparation and to their use. The invention furthermore relates to the use of compounds of the formula I for the pretreatment of hydrophobic surfaces to avoid adsorption of denaturing of proteins.
Patent IL-74394-A0 (IL)
Title: Intravascular laser catheter with fixed focal point
IPC: A61B18/24
Filed: 1985-02-20
Abstract: Apparatus (10) for directing laser energy from a source (28) to a vascular occlusion is disclosed comprising a catheter (12) and a bundle of solid optical fibres (20) disposed in an annular array about the outer wall of the catheter. The distal end (40) of the fibre bundle is bevelled at an angle so as to focus the laser energy to a single focal point (P).
Patent IL-74981-A0 (IL)
Title: Antihypertensive 1,2-benzisothiazole piperidines,a method for synthesizing the same and their use as medicaments
IPC: A61K31/445
Filed: 1985-04-22
Abstract: There are described novel anthypertensive 1,2-benzisothiazole piperidines of the formulawhere X is hydrogen, halogen, loweralkoxy, loweralkyl, nitro, amino or trifluoromethyl; and R isR, being loweralkyl, aryl, aralkyl, cycloalkylloweralkyl or a a loweralkyl substituted with an amino, loweralkylamino or diloweralkylamino, and R<sub>2</sub> being hydrogen, loweralkyl or aryl; antihypertensive compositions comprising said compounds or pharmaceutically acceptable acid addition salts thereof; and methods for synthesizing the same.
Patent IL-75807-A0 (IL)
Title: 2-substituted-1,3-propylidenediphosphonate derivatives,the process for their preparation and pharmaceutical compositions containing them
IPC: C07F9/6509
Filed: 1985-07-15
Abstract: 2-Substituted-1,3-propylidenediphosphonates of formula (I), where A, R1 and R2 are defined in claim 1, are therapeutically active compounds, namely for the treatment of cardiovascular diseases. They can be prepared by reacting phosphonating agents with 1,3- dibromopropanes or ditosylates of 1,3-propanediols substituted in position 2.   <IMAGE> (I)  .
Patent IL-88283-A0 (IL)
Title: Silica for use in tooth paste
IPC: A61K8/00
Filed: 1988-11-03
Abstract: Silica capable of being employed especially in dentifrice compositions. The silica of the invention is characterised in that it has a surface chemistry such that the number of OH expressed as OH/nm<2> is not more than 15 and that its zero charge point (ZCP) is between 3 and 6.5 and a compatibility with zinc of at least 50 %.
Patent IL-93454-A0 (IL)
Title: Optically active arylalkylsulfone derivatives and their preparation
IPC: C07C315/02
Filed: 1990-02-20
Abstract: This invention provides a novel method for the preparation of optically active arylalkylsulfone derivatives, having a chiral center in the alkyl moiety in either the (R)- or the (S)-configuration. These optically active sulfones find use in the stereospecific synthesis of steroid or vitamin D compounds having chiral center at either carbon 24 or carbon 25 of the side chain.
Patent IL-94419-A0 (IL)
Title: Processes for preparing optically active 2-aryl alkanoic acids
IPC: A61K39/00
Filed: 1990-05-16
Abstract: Pharmaceutical preparation consisting of one or more active ingredients and an excipient which solidifies at temperatures between 20 and 80 DEG C and is water soluble, characterized in that it is an isotropic solution in which a) the active ingredient is dissolved in monomolecular or ionic form in the excipient, b) the active ingredient is present in its native conformation and/or its biologically active chiral (enantiomeric) conformation, c) the active ingredient has a mol fraction of 0.001 to 0.67 at 37 DEG C, d) at body temperature, the excipient is molten, single-phase and isotropic, e) the isotropic solution, consisting of excipient and active ingredient, solidifies at ambient temperature, f) the solidified solution is crystalline or non-crystalline or it contains the active ingredient in crystalline form or the latter can crystallize out of the solidified solution, g) the monomolecular or ionic solution has an osmotic pressure and depresses the molar freezing point, h) the dissolved active ingredient present in the polymer electrolyte has a temperature-dependent specific conductivity. A process for obtaining this pharmaceutical preparation is also described.
Patent IL-99537-A0 (IL)
Title: Fibrinogen receptor antagonists and pharmaceutical compositions containing them
IPC: C07D263/48
Filed: 1991-09-20
Abstract: A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
Patent SE-9002918-A0 (SE)
Title: Anordning vid rörämneshantering
Inventor: LARSSON J-O
IPC: B65G57/03
Filed: 1990-09-13
Abstract: Anordning for stapling av rorAmnen pA pallar med hoga sidostottor. TvA gaffelverktyg griper hylsorna invindigt frAn Andarna och lyftes med hjilp av en lyftbom som är vridbart infAst mellan tvA paralella kedjor. Kedjornas rorelsevig beskriver hylsornas vertikala och horisontella lastningsrlirelse.
Patent FI-20002210-A0 (FI)
Inventor: NISSILAE SEPPO
IPC: A61B5/0245
Filed: 2000-10-06
Abstract: A wrist-worn device (100) comprising a display (104) for showing a heart rate parameter value, such as a heart rate measured from a person's body or a heart rate variable derived from the heart rate. The display (104) comprises at least two display areas (104A-104C) which display areas (104A-104C) the wrist-worn device (100) is arranged to employ to show that a heart rate parameter momentarily belongs to a heart rate parameter value range corresponding to the display area (104A-104C) and which wrist-worn device (100) comprises at least one sliding means (112, 112B) for selecting a desired heart rate parameter value range by mechanically sliding the sliding means (112A, 112B) to cover at least one display area (104A-104C) at a time. <IMAGE>
Patent IL-102436-A0 (IL)
Title: High productivity process for the production of maleic anhydride
IPC: C07C51/54
Filed: 1992-07-07
Abstract: An improved process for the manufacture of maleic anhydride by catalytic oxidation of a nonaromatic hydrocarbon having at least four carbon atoms in a straight chain, in which a gas containing oxygen and hydrocarbon is passed through a fixed catalyst bed in a tubular reactor. The activity of the catalyst bed is graded in such manner that the reactor can be operated at an initial (feed gas) hydrocarbon concentration of over 1.5% by volume, an integrated average temperature difference between gas and cooling fluid of at least about 15 DEG  C. over that portion of the bed in which the gas temperature exceeds the cooling fluid temperature, and a productivity of at least about 5.0 lbs. maleic anhydride per hour, without the temperature difference between the gas and the cooling fluid exceeding 80 DEG  C. at any point in the catalyst bed during the course of the reaction. Preferably, the catalyst activity and the gas permeability of the bed vary in the direction of gas flow so that both the catalyst activity and the pressure drop per unit distance are lower in a critical region, where the combination of temperature and hydrocarbon concentration could otherwise cause the reaction to proceed at an excessive rate, than they are in a region of low temperature and low hydrocarbon concentration. Significant and unexpected improvement in reactor performance is achieved by the combination of a graded catalyst charge and incorporation of a catalyst modifying organophosphorus compound in the hydrocarbon feed.
Patent IL-103594-A0 (IL)
Title: Compositions comprising a tramadol material and a nonsteroidal anti-inflammatory drug
IPC: A61K31/19
Filed: 1992-10-29
Abstract: This invention relates to a composition comprising a tramadol material and a nonsteroidal antiinflammatory drug, and its use. The compositions are pharmacologically useful in treating pain and tussive conditions. The compositions are also subject to less opioid side-effects such as abuse liability, tolerance, constipation and respiratory depression. Furthermore, where the components of the compositions are within certain ratios the pharmacological effects of the compositions are superadditive (synergistic).
Patent IL-112813-A0 (IL)
Title: Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
IPC: A61K31/40
Filed: 1995-02-27
Abstract: Diesters of carbonic acid disubstituted with primary, secondary or tertiary amine groups, pharmaceutically acceptable salts thereof, and their use as antiviral and inti-inflammatory agents.
Patent IL-113508-A0 (IL)
Title: Ferritic stainless steel with improved machinability
IPC: C22C38/34
Filed: 1995-04-26
Abstract: Stainless steel contains in %:- less than 0.17C; max. 2Si; max. 2Mn; 11-20Cr; max O.1Ni; max 0.55S; min 30x10-4Ca; min 70x10-40; with ratio of Ca/O being 0.2-0.6.
Patent IL-125797-A0 (IL)
Title: Parapoxviruses which contain foreign dna their preparation and their use in vaccines
IPC: A61K35/76
Filed: 1997-02-17
Abstract: The present invention relates to recombinantly prepared parapoxviruses which carry, in their genomes, deletions or insertions in the form of foreign hereditary information and contain hereditary information, to the preparation of such constructs and to their use in vaccines.
Patent IL-133265-A0 (IL)
Title: Heparanase specific molecular probes and their use in research and medical applications
IPC: A61P35/00
Filed: 1999-04-29
Abstract: A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy. Specific applications include the use of a heparanase specific molecular probe for detection of the presence, absence or level of heparanase expression; the use of a heparanase specific molecular probe for therapy of a condition associated with expression of heparanase; the use of a heparanase specific molecular probe for quantification of heparanase in a body fluid; the use of a heparanase specific molecular probe for targeted drug delivery; and the use of a heparanase specific molecular probe as a therapeutic agent.
Patent IL-134566-A0 (IL)
Title: A process for the biotransformation of colchicone compounds into the corresponding-3- glycosyl derivatives
IPC: C12N1/20
Filed: 1998-09-30
Abstract: The present invention relates to the microbial biotransformation of colchiconic compounds into derivative compounds, which are glycosylated exclusively at the C-3 position of the six-member ring. The process of the present invention provides the 3-O-glycosyl derivatives in high yields and purity.
Patent IL-143475-A0 (IL)
Title: Hepatitis b virus core antigen particles and vaccines and pharmaceutical compositions containing the same
IPC: A61K39/29
Filed: 1999-12-03
Abstract: This invention relates to hepatitis B virus ("HBV") core antigen particles that are characterized by multiple immunogen specificities. More particularly, the invention relates to HBV core antigen particles comprising immunogens, epitopes, or other related structures, cross-linked thereto by ligands which are HBV capsid-binding peptides that selectively bind to HBV core protein. Such particles may be used as delivery systems for a diverse range of immunogenic epitopes, including the HBV capsid-binding peptides, which advantageously also inhibit and interfere with HBV viral assembly by blocking the interaction between HBV core protein and HBV surface proteins. Mixtures of different immunogens and/or capsid-binding peptide ligands may be cross-linked to the same HBV core particle. Such resulting multi-component or multivalent HBV core particles may be advantageously used in therapeutic and prophylactic vaccines and compositions, as well as in diagnostic compositions and methods using them.
Patent IL-165001-A0 (IL)
Title: Inkjet printhead with flex pcb in ink flow path
IPC: B41J2/14
Filed: 2004-11-03
Abstract: A printhead is provided having an assembly of printhead modules. Each printhead module has a support defining fluid chambers, a fluid distributor on the support, and an integrated circuit on the distributor so that fluid in the chambers is distributed to the fluid ejection nozzles of the integrated circuit by the distributor. The support and distributor of each printhead module are shaped to define complementary formations on opposite sides of that printhead module so that the printhead modules are mated together in an angled fashion with the integrated circuits of the mated printhead modules abutting together and diagonally overlapping to define at least one row of fluid ejection nozzles of the printhead.
Patent IL-165696-A0 (IL)
Title: Substituted 1,3-diphenykprop-2-en-1-one derivatives and preparation and uses thereof
IPC: C07C69/738
Filed: 2003-07-08
Abstract: The invention concerns novel substituted 1,3-diphenylprop-2-en-1-one derivatives, pharmaceutical compositions comprising same, their therapeutic uses, in particular for treating cerebral ischemia. The invention also concerns a method for preparing said derivatives.